CTKB

Cytek Biosciences, Inc.
$5.25
-0.16 (-2.96%)
Mkt Cap 682.41M
Volume 1,045,424
52W Range 3.31-6.21
Sector Healthcare
Beta 1.16
EPS (TTM) -0.62 USD
P/E Ratio -9.71
Revenue (TTM) 206.71M USD
Rev Growth (5Y) +16.8%
EPS Growth (5Y) N/A
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue 201.49M 200.45M 193.01M 164.04M 127.95M 92.84M 57.88M
Net Income (66.54M) (6.02M) (12.15M) 2.58M 3.00M 19.41M (16.83M)
EPS -0.52 -0.05 -0.09 0.02 0.03 0.02 -0.13
Free Cash Flow (8.77M) 21.85M 454,000 (22.10M) 266,000 13.61M (14.72M)
FCF / Share -0.07 0.17 0.00 -0.16 0.00 0.10 -0.11
Operating CF (4.69M) 25.38M 5.28M (12.23M) 4.63M 15.16M (13.75M)
Total Assets 461.54M 499.50M 494.46M 519.48M 463.31M 219.98M 70.36M
Total Debt 23.74M 17.02M 14.14M 18.09M 0 2.77M 0
Cash & Equiv 90.85M 98.72M 167.30M 296.60M 364.62M 165.23M 30.12M
Book Value 341.74M 395.74M 393.06M 425.30M 405.04M (16.03M) (41.70M)
Return on Equity -0.19 -0.02 -0.03 0.01 0.01 N/A N/A
CTKB News
Cytek Biosciences (NASDAQ:CTKB) Sets New 12-Month High – Here’s What Happened
Oct 06, 2026 07:01 AM · defenseworld.net
1,315,332 Shares in Cytek Biosciences, Inc. $CTKB Acquired by Bank of America Corp DE
Sep 27, 2026 11:25 PM · defenseworld.net
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Sep 23, 2026 01:00 PM · globenewswire.com
Critical Survey: Revvity (NYSE:RVTY) vs. Cytek Biosciences (NASDAQ:CTKB)
Sep 17, 2026 11:18 PM · defenseworld.net
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?
Sep 17, 2026 05:51 AM · zacks.com
Cytek Biosciences, Inc. (CTKB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Sep 16, 2026 10:01 AM · seekingalpha.com
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
Sep 09, 2026 04:30 AM · globenewswire.com
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
Sep 03, 2026 01:00 PM · globenewswire.com
Deutsche Bank AG Makes New $496,000 Investment in Cytek Biosciences, Inc. $CTKB
Sep 03, 2026 12:06 AM · defenseworld.net
Cytek Biosciences to Participate in Upcoming Investor Conferences
Sep 01, 2026 12:05 PM · globenewswire.com